Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells

Transplantation

Volumn 62, Issue 11, 1996, Pages 1543-1549

  Andoins, Catherine ^a   De Fornel, Daniel ^a   Annat, Jocelyne ^a   Dutartre, Patrick ^a  

^a Laboratoires Fournier SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LF 080299; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; GRAFT REJECTION; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; CARBAMATES; CD4-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030463216     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612150-00003     Document Type: Article

References (47)

1. Hayes JM. The immunobiology clinical use of current immunosuppressive therapy for renal transplantation. J Urol 1993; 149: 437.
2. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
3. + suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
4. Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J Immunol 1994; 153: 3307.
5. 31P nuclear magnetic resonance spectrography, and its effect on rat heart transplantation. Transplantation 1988; 46: 669.
6. Knoop M, Cramer DV, Chapman FC, Makowka L. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat. Transplant Proc 1993; 25: 706.
7. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 1987; 44: 734.
8. Thomson AW. Immunosuppressive drugs and the induction of transplantation tolerance. Transplant Immunol 1994; 2: 263.
9. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566.
10. Jin MX, Engelstad K, Oluwole SF. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells. Transplantation 1992; 54: 113.
11. Kaldany A, George K, Suthanthiran M, Catto GRD, Strom TB, Carpenter CB. Long-term renal allograft survival in rats preimmunized with donor strain RT1.B antigens. Transplantation 1983; 35: 289.
12. Jacobsen N, Taaning E, Ladefoged J, Kristensen JK, Pedersen FK. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 1994; 343: 800.
13. Rosengard Br, Ojikutu CA, Guzzetta PC, et al. Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine. Transplantation 1992; 54: 490.
14. Fishbein JM, Rosengard Br, Gianello P, et al. Development of tolerance to class II-mismatched renal transplants after a short course of cyclosporine therapy in miniature swine. Transplantation 1994; 57: 1303.
15. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
16. Bruley-Rosset M, Churaqui E, Annat J, Dutartre P. LF 08-0299 protects murine recipients of minor antigen disparate donor marrow from lethal graft-versus-host disease. Ann N Y Acad Sci 1995; 770: 373.
17. Annat J, Churaqui E, Dutartre P, Bruley-Rosset M. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299. Transplantation 1996; 62(6): 721.
18. Dutartre P, Annat J, Derrepas P. LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model. Transplant Proc 1995; 27: 440.
19. Klempnauer J, Steiniger B, Lÿck R, Gÿnther E. Genetic control of rat heart allograft rejection: effect of different MHC and non-MHC incompatibilities. Immunogenetics 1989; 30: 81.
20. Westra AL, Petersen AH, Wildevuur CRH, Prop P. Factors determining prolongation of rat heart allograft survival by perioperative injection of donor spleen cells. Transplantation 1991; 52: 606.
21. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
22. 35S] methionine labelled rat lymphoblasts in micro-cytotoxic limiting dilution assays. J Immunol Methods 1996; 192: 117.
23. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. J Immunol 1981; 126: 1614.
24. Walter P, Thies J, Harbauer G, Dickneite G, Sedlacek HH, Vonnahme F. Allogeneic heart transplantation in the rat with a new antitumoral drug-15-deoxyspergualin. Transplant Proc 1986; 18: 1293.
25. Walter P, Dickneite G, Feifel G, Thies J. Deoxyspergualin induces tolerance in allogeneic kidney transplantation 1987; 19: 3980.
26. Hart DNJ, Winearls CG, Fabre JW. Graft adaptation: studies on possible mechanisms in long-surviving rat renal allografts. Transplantation 1980; 30: 73.
27. Lechler RI, Batchelor JR. Mechanisms of reduced immunogenicity of retransplanted rat kidney allografts. Transplant Proc 1983; 15: 316.
28. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990; 248: 1342.
29. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
30. Ferraresso M, Ghobrial R, Stepkowski SM, Kahan BD. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats. Transplantation 1993; 55: 888.
31. Rodrigues MAF, Hutchinson IV, Morris PJ. Alloreactive T suppressor cells in the rat. I. Evidence of three distinct subsets of splenic suppressor T cells resistant to cyclosporine. Transplantation 1989; 47: 847.
32. Bloom Br, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today 1992; 13: 131.
33. Wecker H, Auchincloss H. Cellular mechanisms of rejection. Curr Opin Immunol 1992; 4: 561.
34. Nisco ST, Hissink RJ, Vriens PW, Hoyt EG, Reitz BA, Clayberger C. In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine: radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cells. Transplantation 1995; 59: 1444.
35. Odorico JS, O'Connor T, Campos L, Barker CF, Posselt Am, Naji A. Examination of the mechanisms responsible for tolerance induction after intrathymic inoculation of allogeneic bone marrow. Ann Surg 1993; 218: 525.
36. Bugeon L, Cuturi MC, Paineau J, Anegon I, Soulillou JP. Similar levels of granzyme A and perform mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 1993; 56: 405.
37. Hutchinson IV. Suppressor T cells in allogeneic models. Transplantation 1986; 41: 547.
38. Quigley RL, Wood KJ, Morris PJ. Mediation of antigen-induced suppression of renal allograft rejection by a CD4 (W3/25+) T cell. Transplantation 1989; 47: 684.
39. + T cells. J Immunol 1989; 143: 499.
40. Padberg WM, Lord RHH, Kupiec-Weglinski JW, et al. Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. J Immunol 1987; 139: 1751.
41. Oluwole SF, Reemstma K, Hardy MA. Characteristics and func-tion of suppressor T lymphocytes in immunologically unresponsive rats following pretreatment with UV-B-irradiated donor leukocytes and peritransplant cyclosporine. Transplantation 1989; 47: 1001.
42. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of TH2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
43. Kupiec-Weglinski JW, Wasowska B, Papp I, et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053.
44. Bugeon L, Cuturi MC, Hallet MM, Paineau J, Chabannes D, Soulillou JP. Peripheral tolerance of an allograft in adult rats: characterization by low interleukin-2 and Interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992; 54: 219.
45. Dallman MJ, Wood KJ, Hamado K, et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133: 5.
46. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
47. Lowry R. The relationship of IL-4, IL-10 and other cytokines to transplantation tolerance. Transplant Sci 1993; 3: 104.